Altimmune Inc
NASDAQ:ALT

Watchlist Manager
Altimmune Inc Logo
Altimmune Inc
NASDAQ:ALT
Watchlist
Price: 5.477 USD 2.57%
Market Cap: 571m USD

Wall Street
Price Targets

ALT Price Targets Summary
Altimmune Inc

Wall Street analysts forecast ALT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALT is 18.927 USD with a low forecast of 1.01 USD and a high forecast of 29.4 USD.

Lowest
Price Target
1.01 USD
82% Downside
Average
Price Target
18.927 USD
246% Upside
Highest
Price Target
29.4 USD
437% Upside
Altimmune Inc Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
380% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
CRVO
Diffusion Pharmaceuticals Inc
179% Upside
LVTX
LAVA Therapeutics NV
20% Downside
FDMT
4D Molecular Therapeutics Inc
209% Upside
NBIX
Neurocrine Biosciences Inc
17% Upside
TGTX
TG Therapeutics Inc
44% Upside
OXB
Oxford BioMedica PLC
17% Upside

Revenue
Forecast

Revenue Estimate
Altimmune Inc

For the last 13 years the compound annual growth rate for Altimmune Inc's revenue is -42%. The projected CAGR for the next 3 years is 1 017%.

-42%
Past Growth
1 017%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Altimmune Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Altimmune Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALT's stock price target?
Price Target
18.927 USD

According to Wall Street analysts, the average 1-year price target for ALT is 18.927 USD with a low forecast of 1.01 USD and a high forecast of 29.4 USD.

What is Altimmune Inc's Revenue forecast?
Projected CAGR
1 017%

For the last 13 years the compound annual growth rate for Altimmune Inc's revenue is -42%. The projected CAGR for the next 3 years is 1 017%.

Back to Top